| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
11 |
/ |
2021 |
|
|
|
| |
Data sporządzenia: |
2021-04-13 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
The Retirement of Chief Financial Officer |
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_
today announced the retirement of Joseph D’Agostino, the Company’s Chief Financial
Officer. Mr. D’Agostino, age 70, has been instrumental in overseeing treasury and
cash management, strategic planning, information technology, internal controls, operations,
and financial and tax accounting. Mr. D'Agostino has been Chief Financial Officer
since the Company's founding in March 2011.
The Board of Directors of the Company has hired an executive search firm to assist
in the identification and selection of a new Chief Financial Officer. The Board of
Directors of the Company believes its current financial and accounting team will be
sufficient to support ongoing operations and financial reporting. Mr. D’Agostino will
continue as an advisor to the Company.
|
|
|
RB_ASO: The Retirement of Chief Financial Officer
